$24.83
-0.22(-0.88%)
Mkt Cap $738M
$14.65
$43.04
52-Week Range
At A Glance
1
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers.
2
Revenue is primarily driven by Dermatologic (73.3%) and Non Dermatologic (26.7%).
3
Most recently: Results of Operations and Financial Condition. On February 26, 2026, Castle Biosciences, Inc. (the “Company”) issued a press release announcing its financial re (2026-02-26).
$738M
Market Cap
$349M
Revenue
-$24M
Net Income
Employees784
Fundamentals
How The Business Makes Money
Revenue by Segment
Dermatologic73.3%($657M)
Non Dermatologic26.7%($239M)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0001447362
ISINUS14843C1053
CUSIP14843C105
Phone866 788 9007
Address505 South Friendswood Drive, Friendswood, TX, 77546, US
SEC EDGAR